AI-Enabled Early Detection

Development of an Artificial Intelligence–Enabled Early Detection System for Emerging Human Pathogens under the National One Health Mission IN INDIA
Research Area:-
  • AI-Enabled Early Detection of Emerging Human Infectious Diseases
  • Syndromic Surveillance through Non-Invasive Physiological Signal Monitoring
  • Host-Response Analytics and Pre-Symptomatic Risk Identification
  • Explainable Artificial Intelligence (XAI) for Public Health Decision Support
  • One Health–Aligned Digital Surveillance Systems
  • Wearable-Based Health Monitoring and Anomaly Detection
  • Secure mHealth and Cloud-Integrated Surveillance Architectures
  • Federated and Privacy-Preserving AI for Population-Level Health Monitoring
  • Integration with National Public Health Surveillance and IHR-Compliant Systems
Team / Leads
Sharvesh Adityaji M B

Innovator & Co-Principle Investigator

Shalink & ReyX Infinity Research Hub Pvt. Ltd.

Highlights / Description (Accurate, Referenced): Novelty:

Develops a non-invasive, AI-enabled early warning system that detects pre-symptomatic physiological anomalies associated with emerging human infections. Instead of relying on pathogen-specific diagnostics, the platform analyzes host-response signals using machine learning and explainable AI to generate early risk alerts, supporting proactive public health surveillance under the One Health framework.

Key Features:-
  • Uses non-invasive physiological indicators (e.g., heart rate variability, oxygen saturation, activity and sleep patterns) for anomaly detection.
  • Applies supervised and unsupervised machine learning models to classify health deviations as Normal or Risk-Flagged.
  • Incorporates Explainable AI (XAI) to provide transparent reasoning for each risk alert.
  • Device-agnostic architecture compatible with wearable and mobile health platforms.
  • Designed for integration with public health surveillance systems under the National One Health Mission.
Advantages:-
  • Pathogen-agnostic framework capable of detecting emerging or novel infectious threats.
  • Supports early risk identification before overt clinical symptoms appear.
  • Reduces dependency on immediate laboratory diagnostics in early outbreak phases.
  • Strengthens outbreak preparedness and community-level syndromic surveillance.
  • Aligned with National One Health Mission objectives and WHO IHR surveillance principles.
Practical Benefits:-
  • Non-invasive and infrastructure-light deployment suitable for large-scale public health use.
  • Scalable from pilot institutions to district, state, and national surveillance networks.
  • Privacy-conscious architecture designed for ethical AI use and secure data handling.
  • Adaptable for use in hospitals, community health centers, and institutional monitoring systems.
Scroll